Efficacy and safety of Yokukansan for the treatment-resistant schizophrenia: randomized, double-blind, placebo-controlled multicenter trial
Phase 2
Recruiting
- Conditions
- Treatment-Rsistant Schizophrenia
- Registration Number
- JPRN-UMIN000005018
- Lead Sponsor
- Department of Psychiatry, Shimane University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Personality disorder etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive and Negative Syndrome Scale (PANSS)
- Secondary Outcome Measures
Name Time Method Clinical Global Impression (CGI) Global Assessment of Function (GAF) Drug-induced Extrapyramidal Symptom Scale (DIEPSS)